Key result
A nonfluoroscopic approach to catheter ablation using the CARTO3 system significantly reduced radiation exposure from 556.92 seconds in 2011-2013 to 1.4 seconds in 2014-2017 (P < .001).
Why the study?
Radiation exposure from conventional radiofrequency ablation carries stochastic and deterministic health risks, prompting evaluation of the safety and feasibility of an entirely nonfluoroscopic approach using CARTO3 electroanatomical mapping.
Does an entirely nonfluoroscopic approach using EAM CARTO3 reduce radiation exposure without compromising safety and efficacy in catheter ablation procedures?
Cohort (n=525)
Does an entirely nonfluoroscopic approach using EAM CARTO3 reduce radiation exposure without compromising safety and efficacy in catheter ablation procedures?
Absolute Event Rate: 1.4% vs 556.92%
p-value: p=<.001
Catheter ablation for supraventricular tachycardia and idiopathic ventricular tachycardia can be performed safely and effectively with near-zero or zero fluoroscopy using the CARTO3 system.
Supports feasibility of zero-fluoroscopy ablation with CARTO3; extends observational data but leaves open randomized confirmation of safety and efficacy.
AIMS: The use of electroanatomical mapping (EAM) systems can reduce radiation exposure (RX) and it can also completely eliminate the use of RX. Radiation exposure related to conventional radiofrequency ablation procedures can have a stochastic and deterministic effect on health. The main aim of this study was to evaluate the safety and feasibility of an entirely nonfluoroscopic approach to catheter ablation (CA) using EAM CARTO3. METHODS: In 2011 we started an RX-minimization programme in all procedures using the CARTO system with the deliberate intention to not resort to the aid of RX unless strictly necessary. We divided procedures into two groups (group 1: from 2011 to 2013; group 2: from 2014 to 2017). The only exclusion criteria were the need for transseptal puncture, and nonidiopathic ventricular tachycardia (VT). RESULTS: From a total of 525 procedures, we performed CA entirely without RX in 78.5% of cases. From 2011 to 2013, we performed CA without RX in 38.5% of cases; from 2014 to 2017, we performed 96.2% of cases with zero RX. The use of RX was significantly reduced in group 2 (group 2: 1.4 ± 19.6 seconds vs group 1: 556.92 ± 520.76 seconds; P < .001). These differences were irrespective of arrhythmia treatment. There were no differences between the two groups in acute success, complications, or duration of procedures. CONCLUSION: CA of supraventricular tachycardia and VT entirely without RX, guided by the CARTO system, is safe, feasible, and effective. After an adequate learning curve, CA can be performed entirely without RX.
No takes yet. Share an insight, caveat, or question.
Santoro et al. (2019) conducted a cohort in Supraventricular tachycardia and ventricular tachycardia (n=525). Nonfluoroscopic approach to catheter ablation using EAM CARTO3 (2014-2017) vs. Early radiation minimization approach (2011-2013) was evaluated on Radiation exposure duration (seconds) (p=<.001). A nonfluoroscopic approach to catheter ablation using the CARTO3 system significantly reduced radiation exposure from 556.92 seconds in 2011-2013 to 1.4 seconds in 2014-2017 (P < .001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: